The country is supposed to hold municipal elections every six years, but cash-strapped authorities last held a local ballot in 2016
AstraZeneca’s Covid-19 vaccine performed better than expected in a major late-stage trial, potentially paving the way for its emergency authorisation in the United States and bolstering confidence in the shot after numerous setbacks in Europe.
The drugmaker said on Monday that interim data from trials in Chile, Peru and the United States found the vaccine, developed in conjunction with Oxford University, was 79 per cent effective in preventing symptomatic Covid-19 and, crucially, posed no increased risk of blood clots. It intends to request US emergency authorisation in the coming weeks.
More than a dozen European countries, including Germany and France, had halted use of the AstraZeneca vaccine earlier this month after reports linked it to blood clots in a very small number of people.
The country is supposed to hold municipal elections every six years, but cash-strapped authorities last held a local ballot in 2016
French president says Europe must support firms in AI, green energy
Leaders, former leaders and diplomats meet the former US president and Republican presidential candidate
iCademy Middle East to offer courses with the ability to transfer credits
The historic season opener will feature fighters from the Featherweight and Bantamweight divisions
Under a trial scheme, visitors exploring the city for the day have to buy ticket, with inspectors carrying out spot checks at key entry points
Life Pharmacy’s flagship outlet at Al Wasl has crossed a benchmark of serving over five million customers
This event aims to honour and showcase the remarkable achievements of women and provide an inspiring platform for empowerment and growth